TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/3/21 17:15 | 6/1/21 | ONCR | Oncorus, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Queva Christophe | MA | O | CSO,SVP, | S.m | -393 | 16.68 | 0 | -24 | -33 | 48 | D | ||||||||||||||
5/26/21 16:31 | 5/24/21 | ONCR | Oncorus, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Queva Christophe | MA | O | CSO,SVP, | M.d | 64 | 1.81 | 0 | 36 | 100 | 71 | D | ||||||||||||||
5/4/21 17:33 | 4/30/21 | ONCR | Oncorus, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Queva Christophe | MA | O | CSO,SVP, | S | -376 | 15.97 | 0 | -24 | -40 | 36 | D | ||||||||||||||
4/28/21 19:32 | 4/26/21 | ONCR | Oncorus, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Queva Christophe | MA | O | CSO,SVP, | S.m | -278 | 15.22 | 0 | -18 | -24 | 59 | D | ||||||||||||||
4/8/21 16:57 | 4/6/21 | ONCR | Oncorus, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Queva Christophe | MA | O | CSO,SVP, | S | -80 | 15.01 | 0 | -5 | -6 | 77 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |